To investigate the mechanism through which FCN3 reduces MUFA levels in HCC, we reevaluated the GO analysis results and found that a number of crucial lipid biosynthetic processes were enriched when nsFCN3 was overexpressed in HCC cells (Fig. 5A). Here, FCN3 is linked to hepatocellular carcinoma.